Files in this item
Reorganization of substance use treatment and harm reduction services during the COVID-19 pandemic : a global survey
Item metadata
dc.contributor.author | Radfar, Seyed Ramin | |
dc.contributor.author | De Jong, Cornelis A J | |
dc.contributor.author | Farhoudian, Ali | |
dc.contributor.author | Ebrahimi, Mohsen | |
dc.contributor.author | Rafei, Parnian | |
dc.contributor.author | Vahidi, Mehrnoosh | |
dc.contributor.author | Yunesian, Masud | |
dc.contributor.author | Kouimtsidis, Christos | |
dc.contributor.author | Arunogiri, Shalini | |
dc.contributor.author | Massah, Omid | |
dc.contributor.author | Deylamizadeh, Abbas | |
dc.contributor.author | Brady, Kathleen T. | |
dc.contributor.author | Busse, Anja | |
dc.contributor.author | ISAM-PPIG Global Survey Consortium | |
dc.contributor.author | Potenza, Marc N | |
dc.contributor.author | Ekhtiari, Hamed | |
dc.contributor.author | Baldacchino, Alexander Mario | |
dc.date.accessioned | 2021-05-12T12:30:03Z | |
dc.date.available | 2021-05-12T12:30:03Z | |
dc.date.issued | 2021-04-29 | |
dc.identifier | 273036042 | |
dc.identifier | 6b9f5ef7-fdc2-42c6-965f-f972bff195d9 | |
dc.identifier | 85106509698 | |
dc.identifier | 000652235100001 | |
dc.identifier.citation | Radfar , S R , De Jong , C A J , Farhoudian , A , Ebrahimi , M , Rafei , P , Vahidi , M , Yunesian , M , Kouimtsidis , C , Arunogiri , S , Massah , O , Deylamizadeh , A , Brady , K T , Busse , A , ISAM-PPIG Global Survey Consortium , Potenza , M N , Ekhtiari , H & Baldacchino , A M 2021 , ' Reorganization of substance use treatment and harm reduction services during the COVID-19 pandemic : a global survey ' , Frontiers in Psychiatry , vol. 12 , 639393 . https://doi.org/10.3389/fpsyt.2021.639393 | en |
dc.identifier.issn | 1664-0640 | |
dc.identifier.other | ORCID: /0000-0002-5388-7376/work/93161668 | |
dc.identifier.uri | https://hdl.handle.net/10023/23165 | |
dc.description.abstract | Background: The COVID-19 pandemic has impacted people with substance use disorders (SUDs) worldwide and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health response is categorized around (1) managerial measures and systems, (2) logistics, (3) service providers and (4) vulnerable groups. Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and, 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. 57% of overdose prevention interventions and 81% of outreach services also having been negatively impacted. Conclusions: Participants reported that SUD treatment and harm reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we provide a series of recommendations to support countries to be prepared more efficiently for future waves or similar pandemics to 1) help policymakers generate business continuity plans, 2) maintain use of evidence-based interventions for people with SUDs, 3) be prepared for adequate medication supplies, 4) integrate harm reduction programs with other treatment modalities and 5) have specific considerations for vulnerable groups such as immigrants and refugees. | |
dc.format.extent | 16 | |
dc.format.extent | 3839325 | |
dc.language.iso | eng | |
dc.relation.ispartof | Frontiers in Psychiatry | en |
dc.subject | COVID-19 | en |
dc.subject | Severe acute respiratory syndrome coronavirus 2 | en |
dc.subject | Pandemic | en |
dc.subject | Substance use disorders | en |
dc.subject | Drug addiction | en |
dc.subject | Public health | en |
dc.subject | Drug policy | en |
dc.subject | Opiate agonist treatment | en |
dc.subject | Addiction services | en |
dc.subject | Addiction medicine | en |
dc.subject | RA0421 Public health. Hygiene. Preventive Medicine | en |
dc.subject | RM Therapeutics. Pharmacology | en |
dc.subject | 3rd-DAS | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | SDG 16 - Peace, Justice and Strong Institutions | en |
dc.subject.lcc | RA0421 | en |
dc.subject.lcc | RM | en |
dc.title | Reorganization of substance use treatment and harm reduction services during the COVID-19 pandemic : a global survey | en |
dc.type | Journal article | en |
dc.contributor.institution | University of St Andrews. School of Medicine | en |
dc.contributor.institution | University of St Andrews. Centre for Minorities Research (CMR) | en |
dc.contributor.institution | University of St Andrews. Population and Behavioural Science Division | en |
dc.identifier.doi | 10.3389/fpsyt.2021.639393 | |
dc.description.status | Peer reviewed | en |
dc.identifier.url | https://www.frontiersin.org/articles/10.3389/fpsyt.2021.639393/abstract | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.